Prognostic effect of tumor location in stage II and III colon cancer.

被引：0
|
作者：
Ozveren, Ahmet
Surmeli, Zeki Gokhan
Turgut, Asli
Karaca, Burcak
Karabulut, Bulent
Sanli, Ulus Ali
Uslu, Ruchan
机构：
[1] Ege Univ, Sch Med, Div Med Oncol, Izmir, Turkey
[2] Ege Univ, Sch Med, Izmir, Turkey
[3] Ege Univ, Izmir, Turkey
[4] Ege Univ, Tulay Aktas Oncol Hosp, Sch Med, Izmir, Turkey
[5] Ege Univ, Tulay Aktas Oncol Hosp, Sch Med, Bornova, Turkey
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
10.1200/jco.2015.33.15_suppl.e14652
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14652
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Prognostic impact of mutation profiling in patients with stage II and III colon cancer
    Yinchen Shen
    Xiaohong Han
    Jianfei Wang
    Shuai Wang
    Hongying Yang
    Shih-Hsin Lu
    Yuankai Shi
    Scientific Reports, 6
  • [32] Prognostic impact of mutation profiling in patients with stage II and III colon cancer
    Shen, Yinchen
    Han, Xiaohong
    Wang, Jianfei
    Wang, Shuai
    Yang, Hongying
    Lu, Shih-Hsin
    Shi, Yuankai
    SCIENTIFIC REPORTS, 2016, 6
  • [33] Relationship between primary tumor location and mortality in stage II colon cancer
    Pinto-Torres, S.
    Malheiro, M.
    Rato, J.
    Andre, T.
    Gradil, A.
    Joao, A.
    Braga, S.
    Xavier, A. T.
    Martins, A.
    Fiuza, T.
    ANNALS OF ONCOLOGY, 2017, 28 : 49 - 49
  • [34] The Prognostic Value of Tumor-Infiltrating lymphocytes in Stage II Colon Cancer. A Nationwide Population-Based Study
    Eriksen, Ann C.
    Sorensen, Flemming B.
    Lindebjerg, Jan
    Hager, Henrik
    Christensen, Rene dePont
    Kjaer-Frifeldt, Sanne
    Hansen, Torben F.
    TRANSLATIONAL ONCOLOGY, 2018, 11 (04): : 979 - 987
  • [35] Effect of postoperative complications on adjuvant chemotherapy use in stage III colon cancer.
    Merkow, Ryan P.
    Bentrem, David J.
    Chow, Warren B.
    Cohen, Mark E.
    Ko, Clifford Y.
    Bilimoria, Karl Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [36] Prognostic role of molecular subclassification based on mutational profiling and tumor-associated neutrophil status in stage III colon cancer.
    Chan, C. Y.
    Lo, A. W. I.
    Lam, K. O.
    Ng, H. Y.
    Chen, C. C.
    Lung, M. L.
    Ko, J. M. Y.
    CANCER RESEARCH, 2022, 82 (12)
  • [37] A new prognostic and predictive tool to enhance shared decision making in stage III colon cancer.
    Sobrero, Alberto F.
    Puccini, Alberto
    Shi, Qian
    Grothey, Axel
    Andre, Thierry
    Shields, Anthony Frank
    Ceppi, Marcello
    Bruzzi, Paolo
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [38] Prognostic significance of number versus location of positive mesenteric nodes in stage iii colon cancer
    Kataoka, Kozo
    Ysebaert, Hannes
    Shiozawa, Manabu
    Reynders, Dries
    Ikeda, Masataka
    Tomita, Naohiro
    Goetghebeur, Els
    Ceelen, Wim
    EJSO, 2019, 45 (10): : 1862 - 1869
  • [39] Prognostic Significance of Tumor Deposits in Patients With Stage III Colon Cancer: A Nomogram Study
    Zheng, Peilin
    Chen, Qiaoxing
    Li, Jiake
    Jin, Canguang
    Kang, Lina
    Chen, Donghan
    JOURNAL OF SURGICAL RESEARCH, 2020, 245 : 475 - 482
  • [40] Thymidylate synthase haplotype is associated with tumor recurrence in stage II and stage III colon cancer
    Lurje, Georg
    Zhang, Wu
    Yang, Dongyun
    Groshen, Susan
    Hendifar, Andrew E.
    Husain, Hatim
    Nagashima, Fumio
    Chang, Heung M.
    Fazzone, William
    Ladner, Robert D.
    Pohl, Alexandra
    Ning, Yan
    Iqbal, Syma
    El-Khoueiry, Anthony
    Lenz, Heinz-Josef
    PHARMACOGENETICS AND GENOMICS, 2008, 18 (02): : 161 - 168
12345